Articles Tagged With: ring
-
Long-Lasting, Woman-Controlled Contraception Is Here
Annovera is designed for 21 days of continuous use, followed by a seven-day ring-free interval, during which the ring is removed, washed, and stored. Unlike other products, the same ring is used for subsequent cycles for an entire year (13 cycles total).
-
Researchers Investigate Contraceptive Vaginal Ring
Scientists are now investigating a nonhormonal monthly ring (Ovaprene) as a potential contraceptive. The device involves a permeable mesh in the center of the ring that creates a partial barrier to sperm and locally acting spermiostatic agents to create an inhospitable environment for sperm.
-
Trial Underway for Vaginal Ring Device Designed for HIV Prevention
Researchers are evaluating a vaginal ring designed to protect women against both HIV and herpes simplex virus type 2 in a Phase I study. The trial is being conducted by researchers from the National Institutes of Health-funded Microbicide Trials Network at three U.S. sites in Alabama, California, and Pennsylvania.
-
Researchers Release Initial Results on Developmental Vaginal Ring
In an effort to provide both HIV/AIDS and unintended pregnancy protection, researchers have developed a vaginal ring containing the antiretroviral drug dapivirine and the contraceptive hormone levonorgestrel. Scientists have just released results of an initial clinical trial, noting no safety issues.
-
New Contraceptive Ring Option Receives FDA Approval
Annovera, a soft, reusable, flexible silicone ring containing segesterone acetate and ethinyl estradiol, has been approved by the U.S. Food and Drug Administration.
-
2 studies show monthly vaginal ring protects women against HIV
Results presented at the 2016 Conference on Retroviruses and Opportunistic Infections from two large Phase III clinical trials suggest that a monthly vaginal ring containing the antiretroviral drug dapivirine (and no contraceptives) can safely help prevent HIV-1 infection in women.
-
Monthly Vaginal Ring Helps Protect Women Against HIV
A vaginal ring containing the antiretroviral drug dapivirine helps prevent HIV-1 infection in women. -
Pills, patches, and rings — What’s the latest on the second-tier methods?
What are the benefits and disadvantages of such second-tier methods as pills, patches, and rings, and which women can safely use them? These Tier 2 methods, designated by their effectiveness ranking as adapted by the World Health Organization, depend on user behavior such as taking a pill every day or changing the patch or the ring on time.